SutroVax Announces $85M Series C Financing led by TPG Growth

SutroVax Announces $85M Series C Financing led by TPG Growth SutroVax Announces $85M Series C Financing led by TPG Growth Provides growth capital to advance pneumococcal vaccine to clinic and beyond Preeminent executive vaccinologist, Moncef Slaoui, appointed Board...